Based on the post-operative expression profiles of FLG-AS1, miR-23a-3p, and HOXD10, the ESCC patients were stratified into low-expression and high-expression groups using the median as a cutoff. This evidence concerns the gene HOXD10 and esophageal squamous cell carcinoma.